相关实验视频

Updated: Jul 22, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

化学抗原受体-自然杀手细胞:对潜伏的瘤细胞的有希望的剑

Tahereh Hojjatipour¹, Zahra Sharifzadeh², Amirhosein Maali^2,3

¹Department of Hematology and Blood Transfusion, Students Research Center, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran.

|July 21, 2023

概括

工程自然杀手 (NK) 细胞或CAR-NK细胞提供了一个有前途的癌症免疫疗法. 这些细胞经过基因改造,能够更好地向和破坏瘤,从而有可能克服当前治疗方法的局限性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

自然杀手 (NK) 细胞对于天生的免疫力至关重要,识别和消除癌细胞.
瘤微环境可以诱导免疫衰竭,阻碍NK细胞的有效性.
对NK细胞的基因工程提出了一种增强抗瘤反应的策略.

研究的目的:

审查最近在CAR-NK细胞制造和癌症免疫治疗中的应用方面取得的进展.
将CAR-NK细胞治疗与现有的CAR-T细胞治疗进行比较.
研究CAR-NK细胞疗法的挑战和未来前景.

主要方法:

对用于CAR-NK细胞发育的基因操纵技术的全面审查.
分析CAR构造设计和交付系统的分析.
对CAR工程的各种NK细胞源的评估.
临床前和临床研究数据的综合.

主要成果:

卡尔-NK细胞显示出增强瘤识别和根除的潜力.
卡尔-NK疗法比卡尔-T细胞具有优势,包括先天功能,安全性,体内持久性和现成可用性.
在CAR-NK细胞制造和临床前/临床研究方面取得了重大进展.

结论:

CAR-NK细胞疗法是癌症免疫疗法的新兴和乐观的方法.
需要进一步的研究和开发来克服当前的挑战,并充分实现CAR-NK细胞的潜力.
在各种癌症中,CAR-NK细胞代表了CAR-T细胞治疗的有希望的替代方案.

关键词:

收养细胞疗法采用细胞疗法.在CAR-NK细胞中.癌症免疫疗法癌症免疫疗法化学抗原受体化学抗原受体在 NK 细胞中, NK 细胞是最重要的.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...